Table 5.
Adult Model | References | |
---|---|---|
Population | Healthy Volunteers | |
Drug Parameters | ||
Physicochemical properties | ||
Molecular weight (g/mol) | 804.02 | [36] |
Log Po:w | 3.26 | [36] |
Compound type | neutral | [36] |
Absorption | ||
ACAT model | ||
Peff (10−4 cm/s) | 4.77 | [26] |
Formulation | IR Capsule | |
Solubility @ pH 4.5 ABS buffer—Amorphous formulation (mg/mL) (Reference solubility) |
0.06257 | In-house data |
SGF solubility—Amorphous formulation (mg/mL) | 0.07412 | In-house data |
FaSSIF Solubility—Amorphous formulation (mg/mL) | 0.19655 | In-house data |
FeSSIF Solubility—Amorphous formulation (mg/mL) | 0.60547 | In-house data |
Solubilization ratio—Amorphous formulation | 30300 | Gastroplus fitted |
Solubility @ pH 4.5 ABS buffer—Crystalline (mg/mL) | 0.00165 | In-house data |
SGF solubility—Crystalline (mg/mL) | 0.01003 | In-house data |
FaSSIF Solubility—Crystalline (mg/mL) | 0.00678 | In-house data |
FeSSIF Solubility—Crystalline (mg/mL) | 0.01746 | In-house data |
Solubilization ratio—Crystalline | 11400 | Gastroplus fitted |
Mean particle radius (µm) | 25 | Default value in Gastroplus |
Mean precipitation time (sec) | 900 | Default value in Gastroplus |
Particle density (g/mL) | 1.2 | Default value in Gastroplus |
Distribution | ||
Distribution model | none used | |
PSA input | ||
Dose (mg) | 10.5, 5, 2.5, 1.25 or 0.625 | |
PSA analysis setup | Input value | |
Small intestine fluid volume (minimum) | 0.28% filled (4.0 mL) | |
Small intestine fluid volume (baseline) | 3.15% filled (45.2 mL) | |
Small intestine fluid volume (maximum) | 15.75% filled (225.5 mL) | |
Precipitation time (minimum) | 0.1 s | |
Precipitation time (baseline) | 90 s | |
Precipitation time (maximum) | 900 s |
ACAT model = advanced compartmental absorption and transit model; Peff = effective permeability.